Efficacy and safety assessment of expiratory positive airway pressure rhinobyon for OSAHS therapy

Yaxuan LIU,Yangyang YING,Yan WANG,Shuang DOU,Yanzhong LI,Dedong MA
DOI: https://doi.org/10.6040/j.issn.1673-3770.0.2017.025
2017-01-01
Abstract:Objective Evidence shows that CPAP therapy relying mainly on end-expiratory positive airway pressure (EEPAP) with OSAHS.Therefore,we designed expiratory positive airway pressure (EPAP) rhinobyon and made the efficacy and safety assessment.Methods Six volunteers were enrolled to measure the end-tidal carbon dioxide pressure (PErCO2) while being treated by EPAP rhinobyon under different expiratory pressure.Fourteen OSAHS patients (AHI ≥15/h by PSG) recruited were divided into two groups randomly and treated with CPAP and EPAP rhinobyon for a week respectively.After a week of washing out,the patients were applied with exchanged therapeutic methods for another week.The PSG was performed at the end of each week of treatment with device-on.Results There was no significant difference of PEr CO2 with EPAP therapies under different expiratory pressure and without any therapy (F =1.162,P =0.34).Among the 14 OSAHS patients in both groups,AHI decreased,minimum SaO2 and mean SaO2 increased significantly after treatment (P < 0.001,respectively).There was no significant difference of the efficacy between EPAP rhinobyon and CPAP therapy (P =0.830,0672,0.649;P =0.473,0.636,0.667).Conclusion EPAP rhinobyon therapy was safe and reliable with significant efficacy for selected OSAHS patients.It could be promoted as the substitutive therapy for OSAHS in the future.
What problem does this paper attempt to address?